share_log

Sensei Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Newtyn Management, LLC(6.5%),Newtyn Capital Partners, LP(6.5%), etc.

SEC announcement ·  Nov 3, 2023 17:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more